{"schema":"hottub-news/list/v1","item_schema":"hottub-news/item/v1","count":18,"sponsored":0,"items":[{"id":"n_eovnftukbujxdcpcwkta","seq":1552611,"kind":"article","title":"スウィングス、マウンジャロで6キロ減量「2年に一度覚醒」","title_en":"Swings saw 6kg weight loss with Mounjaro: 'once-in-two-year awakening'","url":"https://www.chosun.com/jp/culture-life-jp/2026/10/03/KFQAFM3JCRCYRNK2XSUMDNIR2I","summary":"【OSEN＝ソン・ミギョン記者】歌手スウィングスが、肥満治療薬で2カ月間に6キロ減量したと明かした。3日、ユーチューブチャンネル「ホン・ヒョンヒ、ジェイソンのホンスンTV」で、「スイスさん、私、英語を学びたいです」と題したコンテンツが公開された。この日、スウィングスはジャケットまできちんと着こなしたしゃれたファッションで、ホン・ヒョンヒ、ジェイソン夫妻の自宅を訪れた。ジャケットを脱ぎながら「タトゥーが見えても大丈夫ですか。消しているところなんですが」","published":"2026-10-03T14:30:00Z","seen":"2026-10-03T15:29:55Z","lang":"ko","country":"KR","source":{"id":"kite-chosun-com-8d8927","name":"chosun.com","domain":"chosun.com","outlet":{"wikidata":"Q483924","name":"The Chosun Ilbo","type":"newspaper","country":"KR","designations":["newspaper"]}},"via":"kite-chosun-com-8d8927","authors":["OSEN"],"entities":[{"id":"Q188688","name":"swing","type":"person"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"image":"https://www.chosun.com/resizer/v2/GNRDKNBWGQ3DSY3BGVTDONJVGU.jpg?auth=24d97e9a6126c530cb424477e026d575347e2473dc3702eb5f2ec557cabd5ed7&height=364&smart=true&width=650","story":"st_eovnftukbujxdcpcwkta","category":"lifestyle-leisure","category_p":0.23,"sentiment":"positive","tone":0.3,"political":0.01},{"id":"n_v5vaj4dixilbj6jmqoua","seq":1552610,"kind":"article","title":"스윙스, 마운자로 효과 봤다..\"6kg 감량, 2년에 한 번 각성\"[핫피플]","title_en":"Swings saw results with Mounjaro: '6kg weight loss, once-in-two-year awakening'","url":"https://www.chosun.com/entertainments/broadcast/2026/10/03/G44TENBTGRTDAOLBHEYDINTDGM","summary":"[OSEN=선미경 기자] 가수 스윙스가 비만 치료제로 두 달 동안 6kg을 감량했다고 밝혔다.3일 유튜브 채널 ‘홍현희 제이쓴의 홍쓴TV’를 통해 ‘스위스씨 저 영어 배우고 싶어요’라는 제목의 콘텐츠가 공개됐다. 이날 스윙스는 재킷까지 갖춰 입은 멋진 패션으로 홍현희, 제이쓴 부부의 집을 찾았다. 그는 재킷을 벗으면서 “타투 나와도 괜찮냐. 지우고 있는데”","published":"2026-10-03T14:30:00Z","seen":"2026-10-03T15:29:55Z","lang":"ko","country":"KR","source":{"id":"kite-chosun-com-8d8927","name":"chosun.com","domain":"chosun.com","outlet":{"wikidata":"Q483924","name":"The Chosun Ilbo","type":"newspaper","country":"KR","designations":["newspaper"]}},"via":"kite-chosun-com-8d8927","authors":["OSEN"],"entities":[{"id":"Q188688","name":"swing","type":"person"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"image":"https://www.chosun.com/resizer/v2/GNRDKNBWGQ3DSY3BGVTDONJVGU.jpg?auth=24d97e9a6126c530cb424477e026d575347e2473dc3702eb5f2ec557cabd5ed7&height=364&smart=true&width=650","story":"st_v5vaj4dixilbj6jmqoua","category":"lifestyle-leisure","category_p":0.5,"sentiment":"positive","tone":0.57,"political":0.01},{"id":"n_lwx5hp7a2gm442diitda","seq":1532123,"kind":"article","title":"« L’arrivée des médicaments antiobésité en France, comme Wegovy et Mounjaro, ne permet pas de prédire la disparition de la grossophobie »","title_en":"The arrival of anti-obesity medications in France, such as Wegovy and Mounjaro, does not predict the disappearance of fat-phobia","url":"https://www.lemonde.fr/idees/article/2026/10/03/l-arrivee-des-medicaments-antiobesite-en-france-ne-permet-pas-de-predire-la-disparition-de-la-grossophobie_6787793_3232.html","summary":"Ces médicaments sont, depuis juin, remboursés sous conditions par l’Assurance-maladie. L’anthropologue Ghislaine Gallenga craint, dans une tribune au « Monde », que cette avancée thérapeutique n’ajoute à la culpabilisation des personnes qui n’auront pas perdu de poids, alors qu’un traitement est disponible.","published":"2026-10-03T12:00:05Z","seen":"2026-10-03T12:36:26Z","lang":"fr","country":"FR","source":{"id":"kite-lemonde-fr-fd885d","name":"lemonde.fr","domain":"lemonde.fr","outlet":{"wikidata":"Q12461","name":"Le Monde","type":"newspaper","country":"FR","designations":["daily newspaper","online newspaper"]}},"via":"kite-lemonde-fr-fd885d","entities":[{"id":"Q133859283","name":"Wegovy","type":"other"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"image":"https://img.lemde.fr/2026/02/25/125/0/1500/750/644/322/60/0/16725db_upload-1-fstl8ibx7rsh-frame-895.jpg","mentions":2,"story":"st_lwx5hp7a2gm442diitda","category":"health","category_p":0.75,"sentiment":"neutral","tone":-0.29,"political":0.13},{"id":"n_72ebmzrsivi3f4rzhxca","seq":1375021,"kind":"article","title":"Tirzepatide cuts fat mass by 35% while preserving skeletal muscle","url":"https://www.news-medical.net/news/20261002/Tirzepatide-cuts-fat-mass-by-3525-while-preserving-skeletal-muscle.aspx","summary":"Tirzepatide cuts body fat while preserving skeletal muscle in real-world study","published":"2026-10-02T14:50:00Z","seen":"2026-10-02T15:22:50Z","lang":"en","source":{"id":"kite-news-medical-net-491c44","name":"news-medical.net","domain":"news-medical.net"},"via":"kite-news-medical-net-491c44","topics":["medicine"],"entities":[{"id":"Q108324770","name":"tirzepatide","type":"other"}],"image":"https://www.news-medical.net/images/news/ImageForNews_848088_17908962299581934.jpg","mentions":2,"story":"st_72ebmzrsivi3f4rzhxca","category":"health","category_p":0.55,"sentiment":"positive","tone":0.56,"political":0.03},{"id":"n_ho37kbtmkkjgq6vfilxq","seq":1330052,"kind":"article","title":"Anyone considering Wegovy and Mounjaro for weight loss issued sleep warning","url":"https://www.cambridge-news.co.uk/news/health/anyone-considering-wegovy-mounjaro-weight-34705887","published":"2026-10-02T09:48:00Z","seen":"2026-10-02T11:33:15Z","lang":"en","country":"GB","source":{"id":"cambridge-news.co.uk","name":"cambridge-news.co.uk","domain":"cambridge-news.co.uk","outlet":{"wikidata":"Q5025487","name":"Cambridge News","type":"newspaper","designations":["newspaper"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Charlotte Smith"],"entities":[{"id":"Q133859283","name":"Wegovy","type":"other"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_452zvnlgrgyrqqwp5mla","category":"health","category_p":0.38,"sentiment":"negative","tone":-0.78,"political":0.05},{"id":"n_452zvnlgrgyrqqwp5mla","seq":1316467,"kind":"article","title":"Sleep warning to anyone considering taking Wegovy and Mounjaro","url":"https://www.mirror.co.uk/news/health/sleep-warning-anyone-considering-taking-37726609","published":"2026-10-02T09:22:00Z","seen":"2026-10-02T10:07:14Z","lang":"en","country":"GB","source":{"id":"mirror.co.uk","name":"mirror.co.uk","domain":"mirror.co.uk","outlet":{"wikidata":"Q217623","name":"Daily Mirror","type":"newspaper","country":"GB","designations":["daily newspaper","newspaper","periodical"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Charlotte Smith"],"entities":[{"id":"Q133859283","name":"Wegovy","type":"other"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_452zvnlgrgyrqqwp5mla","category":"health","category_p":0.27,"sentiment":"negative","tone":-0.71,"political":0.04},{"id":"n_54ktn4p4ztaqizlnccxq","seq":1227602,"kind":"article","title":"Recon: Sanofi, Regeneron expand partnership after Dupixent success; Lilly amylin-Zepbound combo succeeds in mid-stage trial","url":"https://www.raps.org/resource/recon-sanofi-regeneron-expand-partnership-after-dupixent-success-lilly-amylin-zepbound-combo-succeeds-in-mid-stage-trial.html","published":"2026-10-01T19:50:00Z","seen":"2026-10-01T22:23:18Z","lang":"en","source":{"id":"raps.org","name":"raps.org","domain":"raps.org"},"via":"gdelt-gkg-english","topics":["health","economy"],"entities":[{"id":"Q158205","name":"Sanofi","type":"org"},{"id":"Q97159313","name":"Dupixent","type":"other"},{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_7jv5rchntqf2sr24tvoa","category":"health","category_p":0.47,"sentiment":"positive","tone":0.74,"political":0.03},{"id":"n_46bd6mjvtquhk5hiulra","seq":989792,"kind":"article","title":"Novo Nordisk (NYSE: NVO) Ozempic 2 mg Linked To Lower Heart Attack And Stroke Risk Versus Switching To Mounjaro In Real-World Study","url":"https://www.foreignpolicyjournal.com/2026/09/30/novo-nordisk-nyse-nvo-ozempic-2-mg-linked-to-lower-heart-attack-and-stroke-risk-versus-switching-to-mounjaro-in-real-world-study","published":"2026-09-30T17:35:00Z","seen":"2026-09-30T20:08:08Z","lang":"en","source":{"id":"foreignpolicyjournal.com","name":"foreignpolicyjournal.com","domain":"foreignpolicyjournal.com","outlet":{"wikidata":"Q140053273","name":"Foreign Policy Journal","type":"newspaper","country":"US","designations":["online newspaper"]}},"via":"gdelt-gkg-english","topics":["economy","health","science","business"],"authors":["Ewan Scott"],"entities":[{"id":"Q818846","name":"Novo","type":"org"},{"id":"Q47521958","name":"Ozempic","type":"other"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_lbpcbvmwoukdjkwtr7aq","category":"health","category_p":0.81,"sentiment":"neutral","tone":-0.18,"political":0.02},{"id":"n_2t7iomuin4vklce7hz4q","seq":935559,"kind":"article","title":"Combinação experimental da Lilly supera Zepbound em estudo para perda de peso","title_en":"Lilly's experimental combination outperforms Zepbound in weight loss study","url":"https://valor.globo.com/empresas/noticia/2026/09/30/combinao-experimental-da-lilly-supera-zepbound-em-estudo-para-perda-de-peso.ghtml","summary":"A Eli Lilly afirmou nesta quarta-feira (30) que seu medicamento experimental combinado para perda de peso superou o Zepbound, seu produto de grande sucesso, em um estudo comparativo direto, intensificando a concorrência com a rival dinamarquesa Novo Nordisk por novas terapias mais eficazes contra a obesidade. A farmacêutica, sediada em Indianápolis, disse que pacientes com diabetes que receberam a maior dose testada de EloraTZP, combinação de tirzepatida com o medicamento…","published":"2026-09-30T15:12:51Z","seen":"2026-09-30T15:18:22Z","lang":"pt","country":"BR","source":{"id":"kite-pox-globo-com-4344ca","name":"pox.globo.com","domain":"pox.globo.com"},"via":"kite-pox-globo-com-4344ca","topics":["valor"],"entities":[{"id":"Q1073913","name":"Lilly","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"image":"https://s2-valor.glbimg.com/V45MM691g9wKg6v_dlOKf5KmDyo=/i.s3.glbimg.com/v1/AUTH_63b422c2caee4269b8b34177e8876b93/internal_photos/bs/2026/x/X/Mn1OZRQsAqxC0vEhLROA/431631884.jpg","story":"st_iuweffe4hn57djcdktwq","category":"health","category_p":0.28,"category2":"lifestyle-leisure","sentiment":"positive","tone":0.33,"political":0.01},{"id":"n_qqla5nh5lbb2mgjps6ka","seq":926684,"kind":"article","title":"Mounjaro schlägt Wegovy: Neues Abnehmpräparat lässt Konkurrenz weit hinter sich","title_en":"Mounjaro beats Wegovy: New weight loss drug leaves competition far behind","url":"https://www.kreiszeitung.de/wissen/abnehmpraeparate-im-vergleich-mounjaro-uebertrifft-wegovy-deutlich-zr-94518219.html","summary":"Eine klinische Studie zeigt eindrucksvolle Ergebnisse im Konkurrenzkampf um die wirksamsten Abnehmpräparate.","published":"2026-09-30T14:05:00Z","seen":"2026-09-30T14:42:59Z","lang":"de","country":"DE","source":{"id":"kite-kreiszeitung-de-103145","name":"kreiszeitung.de","domain":"kreiszeitung.de","outlet":{"wikidata":"Q1787845","name":"Kreiszeitung","type":"newspaper","country":"DE","designations":["daily newspaper","online newspaper","periodical","website"]}},"via":"kite-kreiszeitung-de-103145","topics":["lower-saxony"],"entities":[{"id":"Q108324770","name":"tirzepatide","type":"other"},{"id":"Q133859283","name":"Wegovy","type":"other"}],"image":"https://www.kreiszeitung.de/assets/images/42/546/42546010-illustration-abnehmspritze-mounjaro-xef.jpg","mentions":8,"story":"st_oxu25apl4tbqkxrdn23a","category":"economy-business","category_p":0.39,"sentiment":"positive","tone":0.47,"political":0.02},{"id":"n_lbpcbvmwoukdjkwtr7aq","seq":918682,"kind":"article","title":"Novo-Funded Analysis Ties Raising Ozempic to 2 mg to Slightly Lower Heart Risk Than Switching to Mounjaro","url":"https://www.medicaldaily.com/ozempic-2mg-vs-mounjaro-switch-heart-risk-novo-analysis-479298","summary":"A Novo-funded claims analysis tied raising Ozempic to 2 mg with 6% lower heart risk than switching to Mounjaro. Here is why confounding matters.","published":"2026-09-30T13:30:12Z","seen":"2026-09-30T14:00:47Z","lang":"en","source":{"id":"kite-medicaldaily-com-05fda3","name":"medicaldaily.com","domain":"medicaldaily.com","outlet":{"wikidata":"Q69052919","name":"Medical Daily","type":"website","country":"US","designations":["website"]}},"via":"kite-medicaldaily-com-05fda3","topics":["medicine"],"entities":[{"id":"Q47521958","name":"Ozempic","type":"other"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"mentions":2,"story":"st_lbpcbvmwoukdjkwtr7aq","category":"health","category_p":0.85,"sentiment":"neutral","tone":0.0,"political":0.02},{"id":"n_pfjikl2ia46l55khagzq","seq":789370,"kind":"article","title":"'Godzilla' fat jab retatrutide sheds more fat than Mounjaro, new study finds - here's when you can get it in Britain","url":"https://www.dailymail.com/health/article-16169509/Godzilla-fat-jab-retatrutide-UK.html","published":"2026-09-29T22:01:00Z","seen":"2026-09-29T23:35:19Z","lang":"en","source":{"id":"dailymail.com","name":"dailymail.com","domain":"dailymail.com"},"via":"gdelt-gkg-english","topics":["economy"],"authors":["Zoe Hardy","ZOE HARDY","HEALTH REPORTER"],"entities":[{"id":"Q6567","name":"Godzilla","type":"other"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_pfjikl2ia46l55khagzq","category":"health","category_p":0.55,"sentiment":"positive","tone":-0.3,"political":0.04},{"id":"n_7yv6sclcqptq27my3xvq","seq":582932,"kind":"article","title":"FDA Flagged GLP-1 Vision Loss Signal in 2025, but U.S. Ozempic and Mounjaro Labels Still Lack NAION Warning","url":"https://www.medicaldaily.com/fda-glp1-naion-signal-us-label-warning-review-479225","summary":"FDA listed NAION as a possible GLP-1 safety signal in March 2025, yet U.S. labels still lack a warning, while Europe, the UK, and Australia have acted.","published":"2026-09-29T04:31:13Z","seen":"2026-09-29T05:12:27Z","lang":"en","source":{"id":"kite-medicaldaily-com-05fda3","name":"medicaldaily.com","domain":"medicaldaily.com","outlet":{"wikidata":"Q69052919","name":"Medical Daily","type":"website","country":"US","designations":["website"]}},"via":"kite-medicaldaily-com-05fda3","topics":["medicine"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q47521958","name":"Ozempic","type":"other"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"mentions":2,"story":"st_7yv6sclcqptq27my3xvq","category":"economy-business","category_p":0.33,"category2":"health","sentiment":"neutral","tone":-0.25,"political":0.17},{"id":"n_w5yatvlseb4mvc6fkwwq","seq":550010,"kind":"article","title":"The forgotten slimming pill that could be better for you than Mounjaro... and it's cheaper: Our experts reveal everything you need to know about the drug - and how it's particularly good for people who binge-eat or have cravings","url":"https://www.dailymail.com/health/article-16166829/The-forgotten-slimming-pill-better-Mounjaro.html","published":"2026-09-29T00:00:00Z","seen":"2026-09-29T00:43:39Z","lang":"en","source":{"id":"dailymail.com","name":"dailymail.com","domain":"dailymail.com"},"via":"gdelt-gkg-english","topics":["economy","health","disaster","education"],"authors":["Kat Lay"],"entities":[{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_w5yatvlseb4mvc6fkwwq","category":"health","category_p":0.52,"category2":"lifestyle-leisure","sentiment":"neutral","tone":0.17,"political":0.01},{"id":"n_mh5xjd733fk2ouvjm3sa","seq":493464,"kind":"article","title":"CagriSema Tops Tirzepatide 5 mg for Weight Loss in REIMAGINE 5","url":"https://www.pharmacytimes.com/view/cagrisema-tops-tirzepatide-5-mg-for-weight-loss-in-reimagine-5","published":"2026-09-28T16:04:00Z","seen":"2026-09-28T18:11:33Z","lang":"en","source":{"id":"pharmacytimes.com","name":"pharmacytimes.com","domain":"pharmacytimes.com","outlet":{"wikidata":"Q27712672","name":"Pharmacy times","type":"website","designations":["scientific journal","website"]}},"via":"gdelt-gkg-english","topics":["health","economy","education"],"entities":[{"id":"Q123427726","name":"cagrilintide/semaglutide","type":"org"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_mh5xjd733fk2ouvjm3sa","category":"health","category_p":0.41,"sentiment":"positive","tone":-0.01,"political":0.04},{"id":"n_qihvgle4zt7ljoak7u5a","seq":458655,"kind":"article","title":"Ozempic and Mounjaro linked to hair loss, particularly in women","url":"http://www.femalefirst.co.uk/health/ozempic-mounjaro-linked-hair-loss-particularly-women-1451291.html","published":"2026-09-28T15:11:30Z","seen":"2026-09-28T15:11:30Z","lang":"en","country":"GB","source":{"id":"femalefirst.co.uk","name":"femalefirst.co.uk","domain":"femalefirst.co.uk"},"via":"gdelt-gkg-english","topics":["economy","education","health"],"entities":[{"id":"Q47521958","name":"Ozempic","type":"other"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_qihvgle4zt7ljoak7u5a","category":"health","category_p":0.69,"sentiment":"negative","tone":-0.63,"political":0.03},{"id":"n_ktxg55jd7gczkwbcz7eq","seq":347800,"kind":"article","title":"GLP-1 hair loss: Do Ozempic, Wegovy, Mounjaro really cause significant hair shedding?","url":"https://timesofindia.indiatimes.com/etimes/wellness/glp-1-hair-loss-do-ozempic-wegovy-mounjaro-really-cause-significant-hair-shedding/articleshow/134531999.cms","published":"2026-09-28T05:25:18Z","seen":"2026-09-28T05:25:18Z","lang":"en","source":{"id":"indiatimes.com","name":"indiatimes.com","domain":"indiatimes.com","outlet":{"wikidata":"Q113974698","name":"Indiatimes","type":"other","country":"IN","designations":["news media"]}},"via":"gdelt-gkg-english","topics":["economy","health","science"],"entities":[{"id":"Q47521958","name":"Ozempic","type":"other"},{"id":"Q133859283","name":"Wegovy","type":"other"},{"id":"Q108324770","name":"tirzepatide","type":"other"}],"story":"st_ktxg55jd7gczkwbcz7eq","category":"health","category_p":0.56,"sentiment":"negative","tone":-0.75,"political":0.07},{"id":"n_juskwfykcyrdkyolvklq","seq":249395,"kind":"article","title":"„Este problematic”: controverse după ce producătorul Mounjaro a sponsorizat evenimentul Vogue World de la Milano Fashion Week","title_en":"“It is problematic”: controversy after Mounjaro producer sponsored Vogue World event at Milan Fashion Week","url":"https://www.g4media.ro/este-problematic-controverse-dupa-ce-producatorul-mounjaro-a-sponsorizat-evenimentul-vogue-world-de-la-milano-fashion-week.html","summary":"Criticii parteneriatului dintre Eli Lilly, compania care produce Mounjaro, și Vogue susțin că asocierea dintre industria modei și un producător de medicamente pentru slăbit riscă să transmită din nou ideea că silueta foarte slabă reprezintă un ideal la care oamenii ar trebui să aspire, scrie The Guardian. Cea de-a cincea ediție Vogue World, eveniment coordonat […] © G4Media.ro .","published":"2026-09-27T12:43:55Z","seen":"2026-09-27T13:19:06Z","lang":"ro","country":"RO","source":{"id":"kite-g4media-ro-035e72","name":"g4media.ro","domain":"g4media.ro","outlet":{"wikidata":"Q88562142","name":"G4 Media","type":"news_agency","country":"RO","designations":["news agency","news website"]}},"via":"kite-g4media-ro-035e72","topics":["fashion","milano fashion week","moda","mounjaro","vogue world"],"authors":["Anne Stănică"],"entities":[{"id":"Q108324770","name":"tirzepatide","type":"org"},{"id":"Q130829","name":"Milan Fashion Week","type":"event"}],"image":"https://www.g4media.ro//wp-content/uploads/2026/09/profimedia-1137434258.jpg","story":"st_juskwfykcyrdkyolvklq","category":"arts-culture-entertainment","category_p":0.45,"category2":"economy-business","sentiment":"negative","tone":-0.33,"political":0.11}]}